# Ironwood Pharmaceuticals, Incorporated

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/ironwood-pharmaceuticals-incorporated/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company in Cambridge, United States |
| OpenAlex ID | https://openalex.org/F4320312269 |
| ROR ID | https://ror.org/05v86fk30 |
| Works | 1,037 |

## Funder papers

- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-outcomes-in-type-2-diabetes-mellitus/)
- [Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial](https://scholariq.org/papers/effect-of-empagliflozin-on-heart-failure-outcomes-after-acute-myocardial/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.